Ubs Asset Management Americas Inc Axogen, Inc. Transaction History

Ubs Asset Management Americas Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.68 - $9.26 $49,317 - $97,581	10,538 New	10,538 $52,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $201,921 - $279,995	21,390 New	21,390 $213,000
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $284,779 - $407,410	-40,741 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $2,972 - $3,924	-167 Reduced 0.41%	40,741 $880,000
Q1 2021 May 14, 2021	BUY	$17.18 - $22.6 $15,255 - $20,068	888 Added 2.22%	40,908 $828,000
Q4 2020 Mar 01, 2021	SELL	$11.5 - $17.96 $72,243 - $112,824	-6,282 Reduced 13.57%	40,020 $716,000
Q3 2020 Nov 13, 2020	BUY	$10.62 - $13.12 $71,929 - $88,861	6,773 Added 17.13%	46,302 $538,000
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $8,283 - $12,182	-1,127 Reduced 2.77%	39,529 $365,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $47,229 - $97,728	5,636 Added 16.09%	40,656 $422,000
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $50,757 - $84,444	-4,540 Reduced 11.48%	35,020 $626,000
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $106,355 - $179,986	8,797 Added 28.6%	39,560 $493,000
Q2 2019 Aug 15, 2019	BUY	$18.5 - $25.47 $200,669 - $276,273	10,847 Added 54.46%	30,763 $0
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $291,171 - $440,741	19,916 New	19,916 $0
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $269,714 - $603,661	-15,782 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $98,744 - $162,110	2,900 Added 22.51%	15,782 $0
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $220,515 - $320,250	6,100 Added 89.94%	12,882 $0
Q1 2018 May 14, 2018	BUY	$24.4 - $40.25 $165,480 - $272,975	6,782 New	6,782 $0

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $763M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.